Wamankar Suchita*, Sahu Tilotma, Shrivastava Saurabh, Kumar Abhishek, Sahu Sagar and Kumar Lokesh
A corona virus disease 2019 (COVID-19) is a contagious disease which is caused by a novel corona virus. Human corona virus (HCoV) recognized as one of the most rapidly evolving viruses owing to its high genomic nucleotide substitution rates and recombination. Among the severe acute respiratory syndrome (SARS) and Middle-East respiratory syndrome (MERS), COVID-19 has spread more rapidly and increased the level of globalization and adaptation of the virus in every environmental condition due to their high rate of molecular diversity. The whole article highlights the general characteristics of corona virus, their molecular diversity, and molecular protein targeting against COVID-19 with their newer approaches. Through this review, an attempt has made to critically evaluate the recent advances and future aspects helpful to the treatment of COVID-19 based on the present understanding of SARS-CoV-2 infections, which may help offer new insights and potential therapeutic targets for the treatment of the COVID-19.
COVID-19, Molecular targeting, Molecular diversity, SARS-CoV-2, Clinical Trials, Future Prospective.
ShriRawatpura Sarkar Institute of Pharmacy, Kumhari, Durg,490042,Chhattisgarh, ShriRawatpura Sarkar Institute of Pharmacy, Kumhari, Durg,490042,Chhattisgarh, ShriRawatpura Sarkar Institute of Pharmacy, Kumhari, Durg,490042,Chhattisgarh, Division of Pharmacology,KIET School of Pharmacy,KIET Group ofInstitutions,Delhi-NCR,Ghaziabad,201206,Uttar Pradesh, Columbia Institute of Pharmacy, Tekari, Raipur, 493111, Chhattisgarh, Siddhi Vinayaka Institute of Technology & Sciences (College of Pharmacy), Bilaspur,495001, Chhattisgarh